Physician profile
Lee E Toney
NPI 1831135730
$713.69
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2022: $45.46 · 2024: $94.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $94.00 | 2024 | |
| Sanofi-Aventis U.S. LLC | $82.49 | 2019 | |
| Amgen INC. | $79.64 | 2019 | |
| Glaxosmithkline, LLC. | $74.16 | 2019 | |
| Novo Nordisk INC | $70.56 | 2019 | |
| Abbvie INC. | $58.42 | 2019-2022 | |
| Pfizer INC. | $47.28 | 2019 | |
| Janssen Pharmaceuticals, INC | $41.93 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $35.40 | 2019 | |
| Daiichi Sankyo INC. | $31.20 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.18 | 2019 | |
| Supernus Pharmaceuticals, INC. | $19.96 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.84 | 2019 | |
| Sanofi Pasteur INC. | $14.96 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.74 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $10.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Toney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.